Articles related to Urology

“The WOLVERINE meta-analysis provides the strongest evidence to date that MDT improves progression-free survival, radiographic progression-free survival, and castration resistance-free survival.” — Tang et al., The Lancet Oncology

Despite the scale of prostate-specific antigen (PSA) testing for prostate cancer screening, prediction models do not predict time-to-event end points or adjust for patient life expectancy.

“The pain may not correlate with the extent of the disease. A patient with severe endometriosis may report little pain while someone with little extent of disease may report much pain.”

Although men in this cohort have a good prognosis, this finding is clinically relevant, as change in PSA is a factor in determining whether men opt to remain on [active surveillance].

“Controlling cancer is, of course, the goal, but there must also be a greater emphasis on life after treatment.”

Survey findings demonstrate that clinical supervisors often send students away before opposite-gender patients enter, believing patients would be uncomfortable, without actually asking for patient consent.